Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 2Phase 4 1

Status

Unknown 4Completed 2

Sponsor Class

OTHER 45INDUSTRY 6UNKNOWN 2OTHER_GOV 2

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 2Sarcoma 1Lymphoid 1Gastrointestinal 1CNS 1

Conditions

Small Cell Lung Carcinoma 1Pleural Effusion, Malignant 1Osteosarcoma 1Lymphoma, T-Cell, Peripheral 1Esophageal Neoplasms 1Brain Neoplasms 1

Interventions

Carboplatin 272Paclitaxel 267Gemcitabine 244Bevacizumab 226Cisplatin 216pembrolizumab 213Docetaxel 210Pemetrexed 162Capecitabine 148Fluorouracil 129Oxaliplatin 121Cyclophosphamide 121Nivolumab 112Dexamethasone 100Trastuzumab 89Leucovorin 87Cetuximab 85Rituximab 83Irinotecan 82Injections 80Erlotinib Hydrochloride 70Prednisone 68Doxorubicin 68Temozolomide 67atezolizumab 65Bortezomib 65Ipilimumab 64Fulvestrant 59Radiotherapy 54Drug Therapy 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × INDUSTRY × endostar protein × Clear all
NCT02520219 2015-08-11

Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study

Nanjing NingQi Medicine Science and Technology Co., Ltd.

Phase 2 Unknown
60 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT00912392 2014-09-03

Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC)

Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd

Phase 2 Completed
138 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT01002092 2014-09-03

A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma

Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd

Phase 2 Unknown
160 enrolled
Sarcoma

Osteosarcoma

NCT01327235 2014-08-01

Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 2 Completed
336 enrolled
Thoracic

Pleural Effusion, Malignant

NCT01368419 2013-04-24

Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 2 Unknown
40 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01410370 2013-04-24

Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain Metastases

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 2 Unknown
80 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡